Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

N
N. McCormick Á. - THROMBIN GENERATION ASSAY: CLINICAL USE IN MONITORING FVIII BYPASSING AGENT THERAPY DURING SURGERY IN A SEVERE HAEMOPHILIA A PATIENT WITH INHIBITOR
Nader H.B. - SYNDECAN-4 CONTRIBUTES TO ENDOTHELIAL TUBULOGENESIS THROUGH INTERACTIONS WITH TWO MOTIFS INSIDE THE PRO-ANGIOGENIC N-TERMINAL DOMAIN OF THROMBOSPONDIN-1
Nadir Y. - HEPARANASE INDUCES TFPI EXPRESSION AND EXTRACELLULAR ACCUMULATION IN ENDOTHELIAL AND TUMOR CELLS
Nadir E. - HEPARANASE INDUCES TFPI EXPRESSION AND EXTRACELLULAR ACCUMULATION IN ENDOTHELIAL AND TUMOR CELLS
Næss I.A. - HOMOCYSTEINE AND RISK FOR VENOUS THROMBOSIS IN A POPULATION-BASED PROSPECTIVE STUDY (HUNT2)
Nafeh M. - MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Nagai N. - NUTRITIONALLY INDUCED OBESITY REDUCES THE ARTERIAL THROMBOTIC TENDENCY OF FACTOR V LEIDEN MICE
Naganuma H. - INDIVIDUAL AND COMBINED EFFECTS OF ASPIRIN AND THIENOPYRIDINES IN ATTENUATION OF PLATELET AGGREGATION INDUCED BY COLLAGEN AND OTHER AGONISTS
Nagasawa T. - POSSIBLE INVOLVEMENT OF CD226 IN CELLULAR INTERACTION OF MEGAKARYOCYTES WITH ENDOTHELIAL CELLS DURING MEGAKARYOPOIESIS AND PLATELET PRODUCTION
  - ROLE OF THE PROAPOPTOTIC BH3-ONLY PROTEIN BIM IN MEGAKARYOPOIESIS AND PLATELET PRODUCTION
Nagaswami C. - THE EFFECT OF FIBRINOGEN GLYCATION ON FIBRIN NETWORK STRUCTURE OF TYPE II DIABETIC SUBJECTS
  - PRONOUNCED B KNOB CAPACITY TO MODULATE FIBRIN ARCHITECTURE, STIFFNESS, AND PLASMIN LYSIS
Naghib A. - COMBINED FACTOR V AND VIII DEFICIENCY, A LARGE GROUP FROM IRAN
Nagura J. - GENETIC POLYMORPHISMS OF ENDOTHELIN CONVERTING ENZYME-1 GENE ASSOCIATED WITH HYPERTENSION IN A JAPANESE POPULATION AND A NOVEL MISSENSE MUTATION IN PREPROENDOTHELIN-1 IN A JAPANESE HYPERTENSIVE
Nagy B. - STUDY OF THE METHYLENETETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM IN HELLP SYNDROME PATIENTS
  - THE OCCURRENCE OF FACTOR V LEIDEN MUTATION IN HUNGARIAN HELLP SYNDROME PATIENTS
Naidu M.R. - NONINVASIVELY MEASURED AORTIC PULSE WAVE VELOCITY FOR DETECTION OF OBSTRUCTIVE CORONARY ARTERY DISEASE
Naik M.U. - JUNCTIONAL ADHESION MOLECULE A (JAM-A) NEGATIVELY REGULATES AGONIST-INDUCED PLATELET ACTIVATION
Naik U.P. - JUNCTIONAL ADHESION MOLECULE A (JAM-A) NEGATIVELY REGULATES AGONIST-INDUCED PLATELET ACTIVATION
  - GENETIC ABLATION OF JAM-A IMPAIRS SURVIVAL AFTER MYOCARDIAL INFARCT
  - THE CENTRAL LINKER OF CALCIUM- AND INTEGRIN-BINDING PROTEIN 1 FUNCTIONS AS A TETHER AND IS CRITICAL FOR BINDING THE CYTOPLASMIC TAIL OF THE INTEGRIN ALPHA IIB SUBUNIT
Naimushin Y.A. - THE INCREASE OF INFLAMMATORY MARKERS IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IS NOT AFFECTED BY GLYCOPROTEIN IIB-IIIA ANTAGONIST EPTIFIBATIDE
Nair S.C. - MUTATIONS IN THE MCFD2 GENE ARE PREDOMINANT AMONG PATIENTS WITH HEREDITARY COMBINED FACTOR V AND FACTOR VIII DEFICIENCY (F5F8D) IN INDIA
  - NINE NOVEL MUTATIONS IDENTIFIED IN GLYCOPROTEINS (GP) IB AND IX GENES AMONG 13 UNRELATED PATIENTS WITH BERNARD SOULIER SYNDROME IN INDIA
  - MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA
  - HEREDITARY DYSFUNCTIONAL FACTOR X IS THAT PASSOVOY FACTOR?
  - COMBINED FACTOR V AND FACTOR VIII DEFICIENCY IN INDIA - A SERIES OF 31 PATIENTS
Nair S. - POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B
Naito S. - INCREASE IN NATTOKINASE ACTIVITY AND VITAMIN K2 CONTENT CAUSED BY DIPICOLINIC ACID
Naitoh K. - IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Nakagaki T. - ADAMTS-13 WITHIN THROMBUS DOWN-REGULATES THROMBUS FORMATION UNDER FLOW CONDITIONS
Nakagawa P. - A NOVEL MUTATION IN EXON 10 OF FACTOR XIII SUBUNIT B
  - PROTEOMIC ANALYSIS IN PLATELET DYSFUNCTION
Nakagawa N. - REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
Nakagawa S. - INCIDENCE OF PULMONARY THROMBOEMBOLISM IN AUTOPSY CASES IN A JAPANESE GENERAL HOSPITAL
Nakagawa P. - FACTOR XIII PHARMACOKINETICS
Nakahara M. - INTRACELLULAR DEGRADATION OF NATURALLY OCCURRING PROTEIN C (PC) MUTANTS
Nakajima M. - PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE
  - THE ANTI-COAGULANT AND THE ANTI-THROMBOTIC EFFECT OF MCC-977, A NOVEL ORALLY-ACTIVE THROMBIN INHIBITOR
Nakajima T. - PREVALENCE OF DEEP VENOUS THROMBOSIS IN A YEAR AFTER THE MID NIIGATA PREFECTURE EARTHQUAKE
  - THE RELATIONSHIP BETWEEN STRANDING IN CARS AND DVT AFTER THE MIDDLE NIIGATA PREFECTURE EARTHQUAKE 2004
Nakamura T. - Pharmacokinetics of a mixture of FVIIa and FX in rats
Nakamura G. - POSSIBLE PLACEMENT OF THE ELUSIVE TAIL OF HEPARIN COFACTOR II REVEALED BY A CRYSTAL STRUCTURE AT LOW IONIC STRENGTH
Nakanishi K. - LIPID RAFT-DEPENDENT ACTIVATION OF NOVEL 33-KDA SER/THR KINASE IN THROMBIN-STIMULATED PLATELETS
  - PHOSPHOINOSITIDE 3-KINASE-INDUCED CYTOSKELETAL TRANSLOCATION OF PROTEIN KINASE CK2 IN THROMBIN-STIMULATED PLATELETS
Nakano Y. - AUGMENTATION OF VASCULAR PERMEABILITY OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IS ENHANCED BY VEGF RECEPTOR 2-BINDING PROTEINS
Nakao S. - CLINICAL SIGNIFICANCE OF PLATELET-DERIVED MICROPARTICLE (PDMP) IN APS: PLASMA LEVELS OF PDMP WERE SIGNIFICANTLY ELEVATED IN APS PATIENTS WITH ARTERIAL THROMBOSES
  - PATHOPHYSIOLOGICAL MECHANISMS OF VASCULOPATHY IN SYSTEMIC SCLERODERMA (SSC): PLATELET ACTIVATION INDUCED BY APL IS ASSOCIATED WITH ARTERIAL THROMBOSES AND DIGITAL PITTING SCAR IN SSC PATIENTS
Nakashima T. - Pharmacokinetics of a mixture of FVIIa and FX in rats
Nakatake H. - HIGH-YIELD PRODUCTION AND CHARACTERIZATION OF RECOMBINANT APROTININ IN SACCHAROMYCES CEREVISIAE
Nakatomi Y. - Pharmacokinetics of a mixture of FVIIa and FX in rats
Nakayama T. - IDENTIFICATION OF AMINO ACID RESIDUES RESPONSIBLE FOR VON WILLEBRAND FACTOR BINDING TO SULFATIDES BY CHARGED TO ALANINE SCANNING MUTAGENESIS
Nakayama K. - IN VIVO PHARMACOLOGICAL STUDIES OF AN ANTI-GPVI ANTIBODY THAT IMMUNODEPLETES GPVI WITHOUT PLATELET ACTIVATION
Nakayama T. - EVALUATION OF LASER-INDUCED THROMBOLYSIS IN THE RAT THROMBOSIS MODELS: A PULSED GREEN LASER TECHNIQUE
Nakazono E. - PHYTOESTROGENS DOWN-REGULATE PROTEIN S EXPRESSION IN HEPG2 CELLS
Nakkinkun Y. - INTRACRANIAL AND SPINAL HEMORRHAGE IN ADULT HEMOPHILIA A IN SIRIRAJ HOSPITAL, THAILAND
  - THE CORRELATION OF SERUM FERRITIN AND PLATELET ACTIVATION IN BETA-THALASSEMIA MAJOR
Namakian F. - THROMBOSIS IN BETA THALASSEMIA MAJOR
  - EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
Nanba M. - EFFECTS OF PITAVASTATIN AND EICOSAPENTAENOIC ACID ON PLATELET-DERIVED MICROPARTICLES AND ADIPONECTIN IN HYPERLIPIDEMIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
Nandurkar H. - MICE TRANSGENIC FOR THROMBOMODULIN EXHIBIT PROTECTION FROM VENOUS THROMBOSIS
  - INCREASED CD39 EXPRESSION PROTECTS KIDNEYS FROM ISCHEMIA REPERFUSION INJURY VIA A REDUCTION IN INFILTRATING CD4+T CELLS: PROTECTION IS AFFORDED BY BOTH EXPRESSIONS ON EITHER TISSUE OR ON CELLULAR BLOOD
Naoe T. - MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
  - FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
  - IDENTIFICATION OF AMINO ACID RESIDUES RESPONSIBLE FOR VON WILLEBRAND FACTOR BINDING TO SULFATIDES BY CHARGED TO ALANINE SCANNING MUTAGENESIS
Naparstek E. - ENHANCED VIABILITY AND EX VIVO EXPANSION AND MATURATION OF CORD BLOOD MEGAKARYOCYTE PROGENITORS (MK-P) WITH FIBRONECTIN
  - HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES VIA NON-ENZYMATIC MECHANISMS
Napoleone E. - LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES
  - TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION
  - INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS
  - WHOLE BLOOD PROCOAGULANT ACTIVITY: A POSSIBILE CELLULAR MARKER OF CARDIOVASCULAR RISK?
Napolitano M. - SUCCESSFUL MANAGEMENT OF BLEEDING WITH A PASTEURIZED FVIII/VWF CONCENTRATE IN A WOMAN AFFECTED BY TYPE 2A VON WILLEBRAND DISEASE UNDERGOING UTERINE CERVIX CONIZATION
Narasimhan K. - HUMAN TISSUE KALLIKREINS, HK6 AND HK10 AS NOVEL BIOMARKERS FOR EPITHELIAL OVARIAN CANCER
Narat S. - MAJOR OBSTETRIC HAEMORRGHAGE IN LATE TERMINATION OF PREGNANCY
  - MAJOR OBSTETRIC HAEMORRHAGE IN LATE TERMINATION OF PREGNANCY
Nardi M.T. - INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY
Nardi M. - BILATERAL THROMBOSIS OF POSTERIOR SHORT CILIORETINAL VESSELS IN A PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, HYPERHOMOCYSTEINE AND ETEROZIGOUS FOR MTHRF
Nardo F. - PLASMA COAGULATION TESTS AND GENETIC THROMBOPHILIC MUTATION STUDIES ARE MANDATORY FOR PREVENTING THE IDIOPATHIC RECURRENT ABORTIONS OR REPEATED FETAL LOSS IN HEALTHY WOMEN
  - THE THERAPEUTICAL STRATEGIES ARE EFFECTIVE TO PREVENT THE RECURRENT ABORTIONS, REPEATED FETAL LOSS OR THE INTRAUTERINE FETAL GROWTH RETARDATION IN WOMEN WITH COAGULATION ABNORMALITIES AND/OR GENETIC THROMBOPHILIC MUTATIONS
Naruko T. - QUANTIFICATION OF BLOOD COAGULATION FACTOR XIII ANTIGEN BY LATEX IMMUNOTURBIDIMETRIC ASSAY
Naseem K.M. - ADIPONECTIN INDUCES AGGREGATION AND ACTIVATION OF HUMAN PLATELETS BY A PHOSPHATIDYL INOSITOL 3-KINASE-DEPENDENT MECHANISM
  - NITRIC OXIDE INHIBITS ADHESION TO COLLAGEN BY MODULATING SENSITIVITY TO PLATELET DERIVED SECONDARY AGONISTS
Naseem A. - CLINICAL OUTCOMES OF POINT-OF-CARE INR MONITORING FOR ANTICOAGULATION IN PRIMARY CARE PRACTICE
Naseem K.M. - THROMBOSPONDIN-1 MODULATES PLATELET SENSITIVITY TO NITRIC OXIDE
Nash M. - IN VIVO RECOVERY OF RISTOCETIN CO-FACTOR IN PATIENTS WITH VON WILLEBRAND DISEASE UNDERGOING PROCEDURES REQUIRING TREATMENT WITH HAEMATE P
Nash M.J. - SUCCESSFUL MANAGEMENT OF LATE OBSTETRIC COMPLICATIONS IN THE ANTIPHOSPHOLIPID SYNDROME
Nasonov E.L. - LONG-TERM OBSERVATION OF 280 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND 74 PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: 10-YEAR FOLLOW-UP
Nataf P. - INCREASED PLASMA MARKERS OF PLATELET AND PROTHROMBIN ACTIVATION IN PATIENTS WITH THORACIC ASCENDING AORTIC ANEURYSM
Natarajan S. - AN AUDIT OF THROMBOPHILIA SCREENING IN A SINGLE PAEDIATRIC TERTIARY REFERRAL CENTRE
Natesha B.K. - PLASMA LEVELS OF COAGULATION AND INFLAMMATORY MARKERS IN SUBJECTS AFFECTED WITH CORONARY ARTERY DISEASE
  - ROLE OF NOVEL LIPOPROTEIN-ASSOCIATED INFLAMMATORY MARKERS IN CORONARY ARTERY DISEASE: A PILOT STUDY
  - ASSOCIATION OF CYTOMEGALOVIRUS (CMV) AND PROATHEROGENIC BIOMARKERS IN CORONARY ARTERY DISEASE (CAD)
  - CORRELATION OF METABOLIC SYNDROME WITH ATHEROGENIC PHENOTYPES IN INDIAN POPULATION
  - CIRCULATING ANTIBODIES TO HEAT SHOCK PROTEINS AND THEIR ASSOCIATION WITH ATHEROTHROMBOTIC PHENOTYPES
  - PATHOGEN BURDEN AND CORONARY ARTERY DISEASE
  - CHLAMYDIA PNEUMONIA INFECTION AND ITS RELATION TO LIPIDS AND INFLAMMATORY MARKERS IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
  - SERUM ADIPONECTIN LEVELS & ITS CORRELATION WITH LIPIDS AND PROINFLAMMATORY MARKERS IN ASIAN INDIAN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
  - APOA1 PROMOTER POLYMORPHISMS AND THEIR ASSOCIATION WITH LIPOPROTEINS IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE (CAD)
  - CONSIDERATION OF MODIFIED CUT-OFFS FOR ANTHROPOMETRIC VARIABLES IN DEFINING METABOLIC SYNDROME AMONG ASIAN INDIANS WITH CORONARY ARTERY DISEASE (CAD)
  - FVII ACTIVITY AND R353Q POLYMORPHISM IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE
  - APPLICATION OF THREE SEPARATE CVD PREDICTIVE SCORES AND THE RELEVANCE OF NOVEL BIOMARKERS TO RISK STRATIFICATION OF ASIAN INDIANS USING THE FRAMINGHAM RISK SCORE
  - HERITABILITY OF C-REACTIVE PROTEIN AND INTERLEUKIN 6 AMONG THE ASIAN INDIAN POPULATION
  - POLYMORPHISMS IN THE IL6 GENE IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE (CAD) -INDIAN ATHEROSCLEROSIS RESEARCH STUDY
Naumchic I.V. - HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOSIS IN BELARUS
Naumnik B. - ACTIVATION OF INTRAVASCULAR COAGULATION DURING HEMODIALYSIS WITH DIFFERENT HEPARINS: A CROSS-OVER STUDY
Navalon F. - SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK
  - SEROTONIN ENHANCES THE PROCOAGULANT PROPERTIES AND PLATELET ACTIVATION INDUCED DURING PLATELET UP TAKE OF TISSUE FACTOR
Navaneetham D. - MECHANISMS OF FACTOR XIA INHIBITION BY TWO KUNITZ TYPE INHIBITORS, PROTEASE NEXIN 2 KPI DOMAIN AND BASIC PANCREATIC TRYPSIN INHIBITOR (BPTI)
Navarrete A.M. - IDENFICATION OF THE RECEPTORS IMPLICATED IN THE ENDOCYTOSIS OF FACTOR VIII BY HUMAN DENDRITIC CELLS
Navarrete A. - VWF INHIBITS OF THE ENDOCYTOSIS OF FACTOR VIII BY MURINE BONE MARROW-DERIVED DENDRITIC CELLS
  - EXPOSED MANNOSYLATION ON THERAPEUTIC FACTOR VIII MEDIATES ITS ENDOCYTOSIS BY HUMAN DENDRITIC CELLS LEADING TO ACTIVATION OF CD4+ T LYMPHOCYTES
  - COMPARISON OF THE IMMUNOGENICITY OF DIFFERENT THERAPEUTIC PREPARATIONS OF HUMAN FACTOR VIII IN THE MURINE MODEL OF HEMOPHILIA A
Navarro F.H. - PRIMARY PROPHYLAXIS WITH RECOMBINANT FACTOR VIIA IN A PATIENT WITH HAEMOPHILIA A AND INHIBITOR
Navarro M. - CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Navarro F.H. - ORTHOPAEDIC SURGERY IN TWO HAEMOPHILIC PATIENTS WITH HIGH-RESPONSE INHIBITORS
Navarro S. - ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION
Navarro J. - TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE 1 (TIMP-1) PREDICTS RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN END STAGE SYSTOLIC HEART FAILURE
Navarro F.H. - NEW THERAPEUTIC APPROACH IN ACQUIRED HEMOFILIA
Navarro S. - PROTHROMBIN AND F1+2 LEVELS ARE SIGNIFICANTLY INCREASED IN SYMPTOMATIC COMPARED WITH ASYMPTOMATIC FAMILY MEMBERS CARRYING THE PROTHROMBIN G20210A MUTATION
Navarro R. - ANKLE REPLACEMENT IN SEVERE BLEEDING DISORDERS: RETROSPECTIVE STUDY ON 17 CASES
Navarro F.H. - SEVERE FACTOR XI DEFICIENCY IN PREGNANT WOMEN: A PROTOCOL FOR LABOUR MANAGEMENT WITH FACTOR XI CONCENTRATE
Navarro I. - SIGNIFICANT REDUCTION OF VASCULAR GRAFT OCCLUSIONS IN CHRONIC HEMODIALYSIS PATIENTS WITH PEG-HIRUDIN (SPP200)
Navarro S. - INCREASED GENERATION OF ACTIVATED PROTEIN C ASSOCIATED WITH OBESITY. WEIGHT LOSS INFLUENCE
Navarro F.H. - PROPHYLAXIS WITH RECOMBINANT FVIIA
Navarro-Núñez L. - INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
Navarro-Nuñez L. - JAK2 V617F MUTATION IS ASSOCIATED WITH THE LEUKOCYTE COUNT AND BONE MARROW CD34+ CELLS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
Navarro-Núñez L. - BETA1-TUBULIN Q43P POLYMORPHISM IS ASSOCIATED WITH A HIGHER INTRACEREBRAL HAEMORRHAGE OCCURRENCE IN MEN
  - FLAVONOIDS INHIBIT PLATELET ADHESION AND AGGREGATION UNDER FLOW: BLOCKADE OF TXA2 RECEPTORS IN PLATELET RICH PLASMA
  - PLATELET FUNCTION (PFA-100) AND ACTIVATION IN PATIENTS WITH CHRONIC PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS: ROLE OF THE JAK2 V617F MUTATION
Navickas I. - POST - CORONARY INTERVENTION RECURRENT ISCHEMIA IN THE PRESENCE OF ADEQUATE PLATELET INHIBITION BY DUAL ANTIPLATELET THERAPY: WHAT ARE WE OVERLOOKING?
Navis G.J. - HIGH ABSOLUTE RISKS AND PREDICTORS OF VENOUS AND ARTERIAL THROMBOEMBOLIC EVENTS IN PATIENTS WITH NEPHROTIC SYNDROME
Nawroth P.P. - THE THROMBOMODULIN PROTEIN C SYSTEM PROTECTS AGAINST DIABETIC NEUROPATHY VIA TWO INDEPENDENT MECHANISMS
  - FACTOR V LEIDEN PROTECTS AGAINST DIABETIC NEPHROPATHY IN MICE
Necasova Z. - DECREASE OF SOLUBLE P-SELECTIN AND INHIBITION BOTH, ACTIVATED FACTOR XA AND THROMBIN AFTER I.V.ENOXAPARIN DURING PCI
Neceva V. - TREATMENT OF DIC AS A COMPLICATION OF POLYTRANSFUSION AT PATIENT WITH OBSTETRIC HEMORRHAGE-CASE REPORT
Needham J. - IMMUNE-TOLERANCE IN HAEMOPHILIA A USING PLASMA-DERIVED FACTOR VIII CONCENTRATE FANHDI
  - EFFECT OF VITAMIN K FOR WARFARIN REVERSAL ON ELEMENTS OF THE TISSUE FACTOR PATHWAY
  - AUDIT OF SCREENING FOR VON WILLEBRANDS DISEASE AND PLATELET FUNCTION ABNORMALITIES USING THE PFA-100
  - THE EFFECT OF THE SUGARBAKER PROCEDURE ON HAEMOSTASIS
Neels M. - AN AUSTRALIAN EXPERIENCE OF RETRIEVABLE INFERIOR VENA CAVA FILTERS IN PATIENTS WITH INCREASED RISK OF THROMBOEMBOLIC DISEASE
  - AN ASSESSMENT OF THE EFFECTIVENESS OF INFERIOR VENA CAVA FILTERS IN PREVENTION OF PULMONARY EMBOLISM BASED UPON DEMONSTRATION OF TRAPPED EMBOLUS AT THE TIME OF FILTER RETRIEVAL
Neerman-Arbez M. - BLEEDING AND THROMBOTIC MANIFESTATION IN 58 PATIENTS WITH CONGENITAL DYSFIBRINOGENEMIA
  - MOLECULAR MECHANISMS ACCOUNTING FOR FIBRINOGEN DEFICIENCY: FROM LARGE DELETIONS TO INTRACELLULAR RETENTION OF MISFOLDED PROTEINS
  - SEVERE FACTOR XI DEFICIENCY IN A JEWISH CHILD CAUSED BY COMPOUND HETEROZYGOTY FOR A NOVEL NONSENSE MUTATION (TYR-14X, EXON 2) AND THE COMMON TYPE II MUTATION (GLU1 17X, EXON 5).L
  - RESCUE IN VITRO OF SECRETION-DEFECTIVE FIBRINOGEN MUTANTS CAUSING AFIBRINOGENEMIA
  - NEONATAL LENTIVIRAL GENE TRANSFER IN A KNOCK-OUT MOUSE MODEL FOR AFIBRINOGENEMIA
  - A NOVEL P.ASP344VAL SUBSTITUTION IN THE FIBRINOGEN GAMMA-CHAIN CAUSES DYSFIBRINOGENEMIA ASSOCIATED WITH THROMBOSIS
Neerman-Arbez M.M. - PRONOUNCED B KNOB CAPACITY TO MODULATE FIBRIN ARCHITECTURE, STIFFNESS, AND PLASMIN LYSIS
Nees M. - GIESSEN THROMBOPHILIA STUDY: MANIFESTATION AGE OF THROMBOEMBOLISM IN THROMBOPHILIA
Neff A. - U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Negaard H.F.S. - ACTIVATED COAGULATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Negrier C. - MONITORING OF RECOMBINANT FVIIA BY THROMBIN GENERATION TEST
  - CONTRIBUTION OF GENETIC ANALYSIS FOR DIAGNOSIS OF VON WILLEBRAND DISEASE TYPE 2B
  - NEUTRALIZING ANTI-FVIII ANTIBODIES HAVE A DIFFERENT IMPACT IN INHIBITING THROMBIN GENERATION
  - THE IMPORTANCE OF TYPE OF QUALITY CONTROL WHEN CHANGING REAGENT BATCHES
  - DETECTION OF LARGE DELETIONS IN HAEMOPHILIA A: CARRIER DETECTION BY MP/LC (MULTIPLEX PCR/LIQUID CHROMATOGRAPHY)
Négrier C. - A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
  - THROMBIN GENERATING CAPACITY IS HIGHLY DECREASED AND DELAYED IN PATIENTS WITH VON WILLEBRAND DISEASE
  - EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX ADMINISTERED BY CONTINUOUS INFUSION IN HAEMOPHILIA B PATIENTS UNDERGOING SURGICAL PROCEDURES
Negrier C. - WALL CLOT GROWTH IN PLASMA: EFFECT OF HIGH DOSES RECOMBINANT FVIIA
  - THROMBIN GENERATION TEST IN THE MONITORING OF PROTHROMBIN COMPLEX CONCENTRATES
Négrier C. - A PROSPECTIVE EFFICACY AND SAFETY STUDY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED FACTOR VIII ADMINISTERED BY CONTINUOUS INTRAVENOUS INFUSION IN SEVERE HAEMOPHILIA A PATIENTS UNDERGOING MAJOR SURGICAL PROCEDURES (PERFACT STUDY)
Negrier C. - THE USE OF FEIBA DURING SURGERIES IN HAEMOPHILIA PATIENTS WITH INHIBITORS TO FACTOR VIII AND IX
Négrier C. - ASSESSMENT OF A METHOD BASED ON LUMINESCENCE DETECTION FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Negrier C. - MRNA ANALYSIS IN A SEVERE HAEMOPHILIA A PATIENT: DETECTION OF AN EXON 6 SKIPPING
Négrier C. - EVALUATION OF IN-VITRO STABILITY AND MICROBIOLOGICAL SAFETY OF RECONSTITUTED VON WILLEBRAND FACTOR CONCENTRATE
Negrotto S. - ROLE OF PPAR-GAMMA ACTIVATION IN MEGAKARYOCYTOPOIESIS
  - IMPAIRED THROMBOPOIESIS AFTER STEM CELL INFECTION WITH JUNIN VIRUS
  - GALECTIN-1 BINDING TO PLATELETS: A NEW MECHANISM FOR PLATELET ACTIVATION
  - DIFFERENTIATION OF CD34+ CELLS MEDIATED BY THROMBOPOIETIN AND MONOCYTES/MACROPHAGES
Neisser-Svae A. - PRION PROTEIN REMOVAL DURING MANUFACTURING OF HIGH-PURITY VWF/FVIII CONCENTRATES
  - PRION PROTEIN (PRPSC) REMOVAL BY CHROMATOGRAPHY PURIFICATION AND NANOFILTRATION OF FIXS AND PCC
Neki R. - THE GENETIC ANALYSIS OF DEEP VEIN THROMBOSIS DURING PREGNANCY AND PERINATAL ASSOCIATED DISORDERS IN JAPANESE
Nelson K. - UPREGULATION OF MICROPARTICLES IN HEPARIN INDUCED THROMBOCYTOPENIA (HIT) AND IT'S MODULATION BY ARGATROBAN
  - UPREGULATION OF SURROGATE MARKERS OF INFLAMMATION AND THROMBOGENESIS IN ESRD PATIENTS, PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS
Nemerson Y. - PHOSPHOLIPID REGULATION OF COAGULATION REACTIONS
  - INHIBITORY ACTIVITY OF TISSUE FACTOR PATHWAY INHIBITOR BETA EXPRESSED BY E COLI AND EXPRESSION IN NORMAL HUMAN TISSUE
Nemes L. - SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE
Nemmar A. - CATHEPSIN G IS NOT A SPECIFIC AGONIST FOR PROTEASE ACTIVATED RECEPTORS IN PLATELETS
Nendaz M. - INFLUENCE OF AGE ON THE COST EFFECTIVENESS OF DIAGNOSTIC STRATEGIES FOR SUSPECTED PULMONARY EMBOLISM
Nepal S. - APIXABAN, AN ORAL DIRECT, FACTOR XA INHIBITOR: SINGLE-DOSE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
  - APIXABAN, AN ORAL DIRECT FACTOR XA INHIBITOR: MULTIPLE-DOSE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS IN HEALTHY SUBJECTS
Nepomnaschy I. - EVALUATION OF VON WILLEBRAND FACTOR IN A MURINE MODEL UNDER STEROID HORMONE TREATMENT
Neporada E.L. - ANTITHROMBIN III IN COMPARISON WITH FRESH FROZEN PLASMA IN THE TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION ACCOMPANIED BY ANTITHROMBIN III DEFICIENCY
Nerme V. - CPU INHIBITION WITH AZD9684: PROFIBRINOLYTIC EFFECTS IN ACUTE PE PATIENTS
Nesbitt W.S. - IDENTIFICATION OF A NOVEL MECHANISM PROMOTING STATIONARY ADHESION OF DISCOID PLATELETS SHEAR DEPENDENT CONVERSION OF PLATELET TETHERS TO PSEUDOPODIA
  - HIGH RESOLUTION IMAGING OF PLATELETS IN VITRO AND IN VIVO
Nesheim M.E. - USE OF THROMBOELASTOGRAPHY TO DEFINE THE ROLE(S) OF NEUTROPHIL ELASTASE DURING NORMAL HAEMOSTASIS IN VITRO
  - CHARACTERIZATION OF A PENTAPEPTIDE THAT MODULATES PROTHROMBINASE ACTIVITY
  - INACTIVATION OF ALPHA-1-PROTEASE INHIBITOR DURING CLINICAL SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IS NOT CONSISTENT WITH INHIBITOR POLYMERIZATION
  - THE DYNAMICS OF THE BINDING OF PLASMINOGEN AND TPA TO IMMOBILIZED HIGH MOLECULAR WEIGHT FIBRIN DEGRADATION PRODUCTS
  - THE INTERACTION OF PROTHROMBIN WITH THE MEMBRANE SURFACE IS A PREREQUISITE FOR OPTIMUM EXPRESSION OF FACTOR VA COFACTOR ACTIVITY WITHIN PROTHROMBINASE
  - A NEW FUNCTIONAL ASSAY FOR MEASURING PLASMA TAFIA AND ITS USE TO DEMONSTRATE TAFI ACTIVATION IN VIVO IN A PRIMATE MODEL
  - THE TIME COURSES OF FIBRIN FORMATION, PROTHROMBIN ACTIVATION AND TAFI ACTIVATION IN NORMAL AND FACTOR VIII-DEFICIENT PLASMA
  - FURTHER EVIDENCE FOR TWO FUNCTIONAL FORMS OF PROTHROMBINASE
Nesterenko I. - THE CLINICAL RELEVANCE OF PLATELET HETEROGENEITY AND ACTIVATION IN PATIENT WITH ANTIPHOSPHOLIPID SYNDROME
Nestola A. - HYDROXYTYROSOL, THE MAJOR OLIVE OIL PHENOLIC ANTIOXIDANT, REGULATES EXPRESSION AND ACTIVITY OF MATRIX METALLOPROTEINASE(MMP)-9 IN HUMAN MONOCYTOID CELLS - POSSIBLE CONTRIBUTION TO PLAQUE STABILITY
Nestoridi E. - ACTIVE SITE-INHIBITED RFVIIA BLOCKS PLATELET STRING FORMATION ON INTACT ENDOTHELIUM ACTIVATED WITH TNF-ALPHA AND SHIGA TOXIN-1
Nestorovic A. - THE 3'UTR PROTHROMBIN GENE POLYMORPHISMS IN THROMBOHILIC SERBIAN POPULATION
Neto C.P.F. - PLASMINOGEN ACTIVATOR INHIBITOR-1 4G/5G POLYMORPHISM IN CORONARY ARTERY DISEASE AND ITS ASSOCIATION WITH PLASMA PAI-1 LEVELS
  - CORONARY ARTERY DISEASE (CAD): LACK OF ASSOCIATION BETWEEN APOB/APOA-I RATIO AND ATHEROMATOSIS EXTENT
  - SECRETORY PHOSPHOLIPASE A2 AND HIGH-SENSITIVITY C-REACTIVE PROTEIN IN CORONARY ARTERY DISEASE
  - ASSOCIATION OF OXIDIZED LDL AND LP(A) LIPOPROTEIN WITH EXTENT OF CORONARY ARTERY DISEASE BY ANGIOGRAPHY
Neudorfer I. - EVIDENCE FOR AN ALTERNATIVE REGULATION OF THE ACTIVITY OF THE BETA3-INTEGRIN ALPHAVBETA3 IN THE ABSENCE OF THE HIGHLY CONSERVED ALPHA-SUBUNIT GFFKR MOTIF
Neufeld J. - IMPROVING PATIENT SAFETY WHEN STARTING WARFARIN IN THE HOSPITAL: THE WARFDOCS STUDY
Neuffer M. - HEPARIN-INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS
Neumann C. - PEROXIREDOXIN, PRDX1 PLAYS AN IMPORTANT ROLE IN INFLAMMATION AND EARLY ATHEROSCLEROSIS
Neumivakin L.V. - SUPERFICIAL THROMBOSIS (RATS AND RABBITS) AND ITS TREATMENT WITH THROMBOLYTIC PREPARATION LONGOLYTIN
  - EXPERIMENTAL MODEL OF THROMBOSIS IN RABBIT'S MARGINAL EAR VEIN
Neville B. - THE PHARMACOKINETICS OF DEFIBROTIDE IN NON-HUMAN PRIMATES IS DOSE DEPENDENT
Neville-Rutherford C. - DETECTION OF PARTIAL F8 GENE DELETIONS IN HAEMOPHILIA A CARRIER DIAGNOSIS
Newall F. - UFH PHARMACOLOGY IN CHILDREN
  - POTENTIAL USE OF AUTOMATED THROMBIN CLOTTING TIME (TCT) ASSAY FOR MONITORING UFH THERAPY
  - MONITORING OF ORAL ANTICOAGULANT THERAPY IN CHILDREN: COMPARISON OF COAGUCHEK XS WITH VENOUS INR
  - UNFRACTIONATED HEPARIN (UFH) PHARMACOKINETICS IN CHILDREN
Newgren J. - MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
  - SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
  - EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
Newman P.J. - HUMAN PLATELETS CIRCULATING IN MICE: APPLICATIONS FOR INTERROGATING PLATELET FUNCTION AND SURVIVAL, THE EFFICACY OF ANTI-PLATELET THERAPEUTICS, AND THE MOLECULAR BASIS OF PLATELET IMMUNOLOGICAL DISORDERS
Newton M. - DEVELOPMENT OF A NOVEL ONE STEP LATERAL FLOW DEVISE FOR QUALITATIVE DETECTION OF PROTHROMBIN FRAGMENT F1+2 IN URINE
Ngata P. - ANTICOAGULANT MANAGEMENT USING AN INTERNET BASED MONITORING SYSTEM
Nguyen C. - COMPLEX MECHANISMS CONTROLLING THE THROMBIN-INDUCED GENERATION OF ENDOTHELIAL MICROPARTICLES
Nguyen H.H. - ELEVATED PLASMA LEVELS OF THROMBOSPONDIN-1 (TSP1) ARE ASSOCIATED WITH INCREASED LEVELS OF TGF-BETA AND PRO-INFLAMMATORY CYTOKINES IN RHEUMATOID ARTHRITIS PATIENTS
Nguyen P. - MONOCYTE IL-10 PRODUCED IN RESPONSE TO LPS MODULATES THROMBIN GENERATION BY INHIBITING TISSUE FACTOR EXPRESSION AND RELEASE OF ACTIVE TISSUE FACTOR-BOUND MICROPARTICLES
Nguyen T.H. - NEONATAL LENTIVIRAL GENE TRANSFER IN A KNOCK-OUT MOUSE MODEL FOR AFIBRINOGENEMIA
Ni H. - IMPAIRED ANGIOGENESIS AND ENHANCED INTRACRANIAL VASCULAR APOPTOSIS IN A MURINE MODEL OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAITP)
  - ROLE OF PLASMA FIBRONECTIN IN FIBRINOGEN/VWF-INDEPENDENT THROMBUS FORMATION
Ni Ainle F.B. - ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
Nicaise P. - A ROLE FOR PLATELET ACTIVATION IN LACUNAR STROKE?
Nichols W.L. - VON WILLEBRAND FACTOR (VWF) MULTIMER ANALYSIS BY IN-GEL IMMUNOSTAINING AND INFRARED IMAGING
Nichols T.C. - PHARMACOKINETICS (PK) OF RVWF IN DOGS AND MICE WITH SEVERE VWD
  - SUCCESSFUL LONG TERM EXPRESSION OF FVIII AFTER GENE DELIVERY OF NOVEL ADENO-ASSOCIATED VIRAL VECTOR SEROTYPES IN HEMOPHILIA A DOGS
Nichols T. - EFFECT OF RFVIIA AND NN1731 (RFVIIA ANALOGUE) ON THROMBOELASTOGRAPHY (TEG) IN WHOLE BLOOD OBTAINED FROM HAEMOPHILIA A DOGS
Nichols T.C. - RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD
Nichols W.L. - A HIGHLY-SENSITIVE PLASMA VON WILLEBRAND FACTOR (VWF):RISTOCETIN COFACTOR ACTIVITY ASSAY BY FLOW CYTOMETRY
Nicholson E. - POTENTIAL ROLE OF RAPID MOLECULAR SCREENING OF PATIENTS WITH DYSFIBRINOGENEMIA
Nicklin S.A. - HEPATIC TARGETING OF ADENOVIRUS MEDIATED BY COAGULATION FACTOR X
Nicolaes G.A.F. - DISCOVERY OF COMPOUNDS THAT INHIBIT FACTOR VA-MEMBRANE INTERACTION BY IN SILICO SCREENING
  - THE ROLE OF THROMBIN EXOSITES I AND II IN THE ACTIVATION OF HUMAN COAGULATION FACTOR V
  - PROS1 ANALYSIS IN 87 PEDIGREES WITH HEREDITARY PROTEIN S DEFICIENCY DEMONSTRATES STRIKING GENOTYPE-PHENOTYPE ASSOCIATIONS
Nicolaes G. - PROTEIN S-C4BP COMPLEX STIMULATES ACTIVATED PROTEIN C-MEDIATED INACTIVATION AT R306 BUT INHIBITS INACTIVATION AT R506 IN FACTOR VA
Nicolaes G.A.F. - DEFINING THE STRUCTURE OF MEMBRANE-BOUND HUMAN BLOOD COAGULATION FACTOR VA
Nicolaisen E.M. - A WHOLE BLOOD CLOTTING METHOD MEASURING EX VIVO EFFECTS OF RFVIIA AND FVIII IN HAEMOPHILIA BLOOD
Nicolas E. - DETECTION OF 23 NOVEL MUTATIONS IN LEBANESE HEMOPHILIA PATIENTS
Nicolas J.F. - IMMUNE RESPONSE AFTER FIRST AND SECOND IV INJECTION OF AVIDIN USED AS THE NEUTRALIZING AGENT FOR BIOTINYLATED IDRAPARINUX
Nicolucci A. - PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN
Niego B. - DESMOTEPLASE-MEDIATED PLASMINOGEN ACTIVATION AND CLOT LYSIS ARE ANTAGONIZED BY THE LYSINE ANALOGUE TRANEXAMIC ACID
Nieman M. - THROMBOSTATIN FM19 - A THROMBIN RECEPTOR ACTIVATION ANTAGONIST
Niemann S. - ACTIVATED PLATELETS ENHANCE THE ADHERENCE TO AND INVASION OF ENDOTHELIAL CELLS BY STAPHYLOCOCCUS AUREUS
Niessen F. - THE TISSUE FACTOR CYTOPLASMIC DOMAIN REGULATES PROCOAGULANT RESPONSES IN MACROPHAGES
Nieswandt B. - RHOA IS ESSENTIAL FOR MEGAKARYOCYTE SURVIVAL IN VIVO
  - RAC1 IS AN EFFECTOR OF THE GPVI SIGNALING CASCADE IN PLATELETS
  - UNALTERED CA2+ HOMEOSTASIS AND AGONIST-INDUCED ACTIVATION IN PLATELETS LACKING TRANSIENT RECEPTOR POTENTIAL (TRP) C1
  - HOT TOPIC DEFECTIVE ACTIVATION OF PLATELET INTEGRINS IN TALIN-DEFICIENT MICE
  - COFILIN, BUT NOT ADF, IS ESSENTIAL IN PLATELET FORMATION IN VIVO
  - DOUBLE-DEFICIENCY OF RAC1 AND CDC42 SEVERELY AFFECTS PLATELET PRODUCTION AND FUNCTION
  - AN EF-HAND MUTATION IN STIM1 CAUSES PREMATURE PLATELET ACTIVATION AND BLEEDING IN MICE
  - INHIBITION OF GPIB, BUT NOT GPIIB/IIIA, IMPROVES EXPERIMENTAL STROKE OUTCOME WITHOUT BLEEDING COMPLICATIONS
Nieto J. - INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
Nieuwland R. - CELL-DERIVED MICROPARTICLES AND COMPLEMENT ACTIVATION IN PREECLAMPSIA VERSUS NORMAL PREGNANCY
  - PLATELET MICROPARTICLES CONTAIN ACTIVE CASPASE 3
  - GENDER AND MENSTRUAL CYCLE INFLUENCE CIRCULATING MICROPARTICLES
  - MICROPARTICLES DURING THE COURSE OF PAINFUL CRISES IN SICKLE CELL DISEASE
  - INHIBITION OF MICROPARTICLE RELEASE TRIGGERS ENDOTHELIAL APOPTOSIS
  - RETRANSFUSION OF PERICARDIAL BLOOD DOES NOT TRIGGER SYSTEMIC COAGULATION DURING CARDIOPULMONARY BYPASS
  - SIMVASTATIN-INDUCED ENDOTHELIAL CELL DETACHMENT AND MICROPARTICLE RELEASE ARE PRENYLATION DEPENDENT
  - ANALYSIS OF MICROPARTICLES IN DEEP VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS AND CARRIERS OF LEIDEN FACTOR V
  - COAGULANT PROPERTIES OF MICROPARTICLE-ASSOCIATED FUSION PRODUCTS OF FULL LENGTH AND ALTERNATIVELY SPLICED HUMAN TISSUE FACTOR WITH GREEN FLUORESCENT PROTEIN
Niggli F. - PORT--CATH-RELATED THROMBOSIS AND POSTTHROMBOTIC SYNDROME IN PAEDIATRIC ONCOLOGY PATIENTS: THE PACTOP STUDY
Nigro C. - OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
Niimi M. - EPITOPE MAPPING OF COLLAGEN BINDING SITE IN HUMAN GLYCOPROTEIN VI (GPVI)
Niinobu T. - INCIDENCE OF PULMONARY THROMBOEMBOLISM IN AUTOPSY CASES IN A JAPANESE GENERAL HOSPITAL
Niitshu Y. - FLOW CYTOMETRIC ANALYSIS OF VASP PHOSPHORYLATION IN PLATELETS TREATED WITH THE ACTIVE METABOLITE OF PRASUGREL, A P2Y12 ADP RECEPTOR ANTAGONIST
Niitsu Y. - COMPARISON OF ANTIPLATELET AND ANTITHROMBOTIC EFFECTS OF PRASUGREL AND AZD6140
Niiya M. - OVEREXPRESSION OF ADAMTS13 BY LENTIVIRAL VECTOR ENCODING HUMAN ADAMTS13 GENE OFFERS SYSTEMIC PROTECTION AGAINST ARTERIAL THROMBOSIS IN A MOUSE MODEL
Nijkeuter M. - SPIRAL COMPUTED TOMOGRAPHY IN THE EVALUATION OF THE RESOLUTION OF PULMONARY EMBOLISM AFTER A STANDARD COURSE OF ANTICOAGULATION
  - RISK FACTORS FOR MORTALITY THREE MONTHS AFTER PULMONARY EMBOLISM
  - HIGH D-DIMER LEVEL INCREASES THE LIKELIHOOD OF PULMONARY EMBOLISM IN A HIGH-RISK POPULATION
  - COMPARISON OF THE REVISED GENEVA RULE WITH WELLS RULE FOR ASSESSING CLINICAL PROBABILITY OF PULMONARY EMBOLISM
  - PULMONARY EMBOLISM FAILURE RATE IN PATIENTS IN WHOM PULMONARY EMBOLISM WAS RULED OUT BY LOW AND INTERMEDIATE PROBABILITY BY THE REVISED GENEVA SCORE AND A NORMAL QUANTITATIVE D-DIMER TEST RESULT
  - HEART-TYPE FATTY ACID BINDING PROTEIN IS PREDICTIVE FOR MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
  - CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
Nikitina L.A. - GENETIC POLYMORPHISM R353Q OF FACTOR VII HAS PROTECTIVE EFFECT IN THREATENED MISCARRIAGE
Nikolaides N. - HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES
Nikolajeff F. - A NOVEL HIGHLY PROMISING POINT-OF-CARE METHOD FOR HIV MONITORING
Nikolajek K. - GENDER AND MENSTRUAL CYCLE INFLUENCE CIRCULATING MICROPARTICLES
Nilsen D.W.T. - NT-PROBNP, AND NOT TF, FM, PAPP-A, MPO OR CD40 LIGAND, PREDICTS RECURRENT TROPONIN-T POSITIVE CARDIAC EVENTS FOLLOWING AN ACUTE MYOCARDIAL INFARCTION
  - ACTIVATED FACTOR XII TYPE A INDEPENDENTLY PREDICTS 12 MONTH MORTALITY IN CHEST PAIN PATIENTS
Nilsson B. - ACTIVATION OF BLOOD COAGULATION IN AB0-COMPATIBLE BLOOD BY MULTIPOTENT MESENCHYMAL STROMAL CELLS
Nilsson C. - CLINICAL PROBABILITY ASSESSMENT AND D-DIMER DETERMINATION IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS: COMPARISON BETWEEN LOCAL D-DIMER METHOD AND CENTRALIZED ANALYSIS IN BATCH
  - CLINICAL PROBABILITY ASSESSMENT AND D-DIMER DETERMINATION IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS: COMPARISON BETWEEN LOCAL D-DIMER METHOD AND CENTRALIZED ANALYSIS IN BATCH
Nilsson B. - FACTOR XII-MEDIATED CONTACT ACTIVATION OCCURS ON THE SURFACE OF THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP)-ACTIVATED PLATELETS
Nilsson K. - ESTROGEN TREATMENT OF CONSTITUTIONAL TALL STATURE IN GIRLS: RISK OF THROMBOSIS OR BLEEDING?
Nilsson Ekdahl K. - FACTOR XII-MEDIATED CONTACT ACTIVATION OCCURS ON THE SURFACE OF THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP)-ACTIVATED PLATELETS
Nimjee S.M. - DEVELOPING ANTIDOTE CONTROLLED ANTIPLATELET THERAPIES BY TARGETING THE VWF - GP IB-IX-V INTERACTION
Ning H. - EARLY EXCLUSION OF MYOCARDIAL INFARCTION IN PATIENTS WITH CHEST PAIN BY TROPONIN I IN CONJUNCTION WITH D-DIMER
Nishida Y. - CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Nishihira K. - MECHANISMS OF THROMBUS FORMATION DIFFER BETWEEN ATHEROSCLEROTIC AND NORMAL ARTERIES IN HYPERCHOLESTEROLEMIC RABBITS
Nishio M. - INTRACELLULAR DEGRADATION OF NATURALLY OCCURRING PROTEIN C (PC) MUTANTS
Nishioka J. - REGULATION OF PROTEIN S EXPRESSION IN HEPATOCYTES AND SINUSOIDAL ENDOTHELIAL CELLS IN RATS WITH CIRRHOSIS
  - REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
Nishiura T. - PLATELET VOLUME IN CORD BLOOD
Nishiyama Y. - A COVALENT REACTIVE ANTIGEN ANALOG TO FACTOR VIII REDUCES ANTIBODY PRODUCTION IN MEMORY B CELLS AFTER RE-STIMULATION WITH FVIII
Nissinen L. - PLATELET INTEGRIN ALPHA2BETA1 INTERACTION WITH TYPE I COLLAGEN IS INHIBITED BY A NOVEL SYNTHETIC MOLECULE BTT-3016
Nithyanath M. - MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA
Nivet-Antoine V. - IS MODIFICATION OF DIET IN RENAL DISEASE (MDRD) FORMULA SIMILAR TO COCKCROFT-GAULT FORMULA TO ASSESS RENAL FUNCTION IN ELDERLY HOSPITALIZED PATIENTS TREATED WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)?
Nixon J. - PEGYLATION PROTECTS FACTOR VIII FROM THE INHIBITION OF ANTIBODY INHIBITORS
  - MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
Nizard J. - CUTANEOUS REACTION TO LOW MOLECULAR WEIGHT HEPARIN AND HOMOZYGOUSIS FOR FACTOR V LEIDEN MUTATION DURING PREGNANCY: A CASE REPORT
Njolstad I. - FAMILY HISTORY OF MYOCARDIAL INFARCTION (MI) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
  - MEAN PLATELET VOLUME (MPV) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
Nobecourt C. - ROTEM THROMBOELASTOMETRY IN OBSTETRIC: NEAR PATIENT-TEST AS AN EARLY PREDICTOR OF POST-PARTUM HEMORRHAGE (PPH)
Nobili E. - ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION
Nobori T. - ADAMTS13 RELATED MARKERS IN PLASMA FROM PATIENTS WITH TTP
  - ELEVATED D-DIMER LEVELS IN PATIENTS WITH DEEP VEIN THROMBOSIS
Noguchi M. - INCREASED THROMBIN GENERATION CAPACITY IN SEPTIC PATIENTS WITH DIC
  - INCREASED LEVELS OF D-DIMER IN PATIENTS WITH MYOCARDIAL INFARCTION
Nogueras C. - ROLE OF 4G/5G PROMOTER POLYMORPHISM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN OUTCOME OF SEPSIS
Nokes T. - VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
Nolan B. - ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
Nolasco L. - SHEAR-INDUCED DISULFIDE BOND FORMATION REGULATES ADHESION ACTIVITY OF VON WILLEBRAND FACTOR
Nolte M.E. - EFFECT OF RECOMBINANT FACTOR VIIA VARIANT (NN1731) ON PLATELET FUNCTION, CLOT STRUCTURE AND FORCE ONSET TIME IN BLOOD FROM HEALTHY VOLUNTEERS AND HEMOPHILIA PATIENTS
Nomdedeu J. - GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT
Nomura S. - EFFECTS OF PITAVASTATIN AND EICOSAPENTAENOIC ACID ON PLATELET-DERIVED MICROPARTICLES AND ADIPONECTIN IN HYPERLIPIDEMIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
Nomura M. - TRANSFUSION OF FRESH FROZEN PLASMA AND PLATELETS TO ACHIEVE HEMOSTASIS DURING CARDIOVASCULAR SURGERY INCREASES THE RISK OF POSTOPERATIVE INFECTION
Nonaka S. - A NOVEL FIBRINOLYTIC FACTOR ADIPOMIN REGULATES ADIPOSITY
Nonne C. - VASCULAR WALL ALTERATIONS AND MATRIX EXPOSURE FOLLOWING LASER-INDUCED INJURY OF MOUSE MESENTERIC ARTERIOLES
  - MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
Nordenholz K.E. - DECLINING RATE OF VENOUS THROMBOEMBOLISM IN PATIENTS EVALUATED FOR PULMONARY EMBOLISM IN TWO UNITED STATES EMERGENCY DEPARTMENTS AND LOW RATE OF EMPIRIC ANTICOAGULATION
  - TANDEM MEASUREMENT OF D DIMER AND MYELOPEROXIDASE DECREASES UNNECESSARY PULMONARY VASCULAR IMAGING IN EMERGENCY DEPARTMENT PATIENTS EVALUATED FOR PULMONARY EMBOLISM
  - EVALUATION OF 50 POTENTIAL MARKERS OF PULMONARY EMBOLISM FOR USE IN THE EMERGENCY DEPARTMENT
  - MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
Norengaard L. - ROTEM THROMBELASTOMETRY ANALYTICAL CONTROL, VARIATION, AND VALIDATION USING A FROZEN PLATELET RICH PLASMA CONTROL AND ACTIVATION WITH MINUTE AMOUNTS OF TISSUE FACTOR
  - DETECTION OF FUNCTIONAL FACTOR VII INHIBITORS IN PLASMA
  - EVALUATION OF COAGULATION KINETICS USING THROMBELASTOGRAPHY
Noris P. - MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
  - CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS
Norman K.E. - INHIBITION OF THROMBOSIS BY AZD6140 VIA SELECTIVE BLOCKADE OF THE P2Y12 RECEPTOR IN A MURINE LASER-INJURY MODEL
Norris L.A. - SEX STEROIDS USED IN HORMONE TREATMENT ALTER COAGULATION GENE EXPRESSION IN CULTURED HUVEC
  - DIFFERENTIAL EFFECTS OF TRANSDERMAL AND ORAL ESTRADIOL/NORETHISTERONE ACETATE HORMONE THERAPIES ON COAGULATION AND FIBRINOLYTIC MARKERS
Nosal M. - C-REACTIVE PROTEIN, LIPOPROTEIN(A) AND HOMOCYSTEINE AS CONTRIBUTORS TO FIBRIN CLOT PERMEABILITY AND LYSABILITY IN SUBJECTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING
Nossent A.Y. - ASSOCIATION OF BLOOD PRESSURE AND FACTOR VIII IN LEIDEN THROMBOPHILIA STUDY (LETS) AND CARDIOVASCULAR HEALTH STUDY (CHS)
  - AQUAPORIN 2 GENE VARIATIONS, LEVELS OF VON WILLEBRAND FACTOR AND FACTOR VIII AND THE RISK OF VENOUS THROMBOSIS
  - FUNCTIONALITY OF THE VASOPRESSIN 2 RECEPTOR VARIATION G12E AS MODIFIER OF VON WILLEBRAND FACTOR AND FACTOR VIII LEVELS
Nothen M. - HEREDITARY ANGIOEDEMA TYPE III ARE CAUSED BY A GAIN OF FUNCTION MUTATION IN COAGULATION FACTOR XII, WHICH INCREASES VASCULAR PERMEABILITY MEDIATED BY BRADYKININ GENERATION
Notley C. - THE EFFECT OF EXERCISE ON INDIVIDUALS WITH TYPE 1 AND TYPE 2B VON WILLEBRAND DISEASE (VWD)
  - PLATELET TYPE VON WILLEBRAND DISEASE: AN UNDERDIAGNOSED CAUSE OF EXCESSIVE MUCOCUTANEOUS BLEEDING
  - CHALLENGES IN DEFINING TYPE 2M VON WILLEBRAND DISEASE: RESULTS FROM A CANADIAN COHORT STUDY
Notley C.R.P. - POLYMORPHIC AND MUTAGENIC SEQUENCE CHANGES IN THE A1 AND A2 DOMAINS OF VON WILLEBRAND FACTOR (VWF) RESULT IN ALTERATIONS TO ADAMTS13 CLEAVAGE EFFICIENCY
  - INFLUENCE OF A GT REPEAT ELEMENT ON SHEAR STRESS-RESPONSIVENESS OF THE VWF GENE PROMOTER
Novak N. - INTERLEUKINS GENES TAG-SNP HAPLOTYPES AND RISK OF MYOCARDIAL INFARCTION: A POPULATION BASED CASE-CONTROL STUDY
  - TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION
Novak P. - THROMBIN GENERATION TEST AN EXPERIENCE OF ONE CENTRE IN THROMBOPHILIA PATIENTS
  - AGGREGATION TEST FOR DETECTION CLOPIDOGREL RESISTANCE
Novakov Mikic A. - PROPHYLACTIC APPROACH TO WOMEN WITH THROMBOPHILIA AND REPEATED SPONTANEOUS ABORTIONS
Novakova I.R.O. - PLASMA PROTEOMICS IN HEMOPHILIA A PATIENTS AFTER FVIII ADMINISTRATION
  - THE DUAL ROLE OF INTRINSIC GENERATED PLASMIN IN THE REGULATION OF THE HEMOSTATIC BALANCE
Nováková I.R.O. - TWO NOVEL MUTATIONS AND FOUR NOVEL POLYMORPHISMS IN THE FACTOR VII GENE
Novakova I.R.O. - THE RISK OF INHIBITOR DEVELOPMENT IN 1104 PATIENTS WITH HEMOPHILIA A ACCORDING TO FACTOR VIII GENOTYPE
  - THE ROLE OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) AND MEGALIN RECEPTOR IN THE CLEARANCE OF FACTOR VIII IN HUMANS
Nováková I.R.O. - IN VIVO AND IN VITRO EFFECTS OF RECOMBINANT ACTIVATED FACTOR VII ON THE PLATELET PROTEOME
Novakovic V. - INHIBITOR ANTIBODY LE2E9 AGAINST FACTOR VIII C1 DOMAIN INHIBITS PHOSPHOLIPID BINDING AND ALTERS FACTOR XASE ENZYME COMPLEX FORMATION
Noventa F. - GRADUATED COMPRESSION STOCKINGS (GCS) VERSUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PREVENTION OF DEEP VEIN THROMBOSIS (DVT) AFTER KNEE ARTHROSCOPY (KA). A RANDOMISED STUDY (KANT)
  - THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AFTER DISCONTINUING ANTICOAGULATION IN PATIENTS WITH ACUTE PROXIMAL DEEP VEIN THROMBOSIS OR PULMONARY EMBOLISM. A PROSPECTIVE COHORT STUDY
  - DETECTION OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES: THE INFLUENCE OF DIFFERENT ANTIGEN PREPARATIONS
Novikov A.A. - LONG-TERM OBSERVATION OF 280 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND 74 PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: 10-YEAR FOLLOW-UP
Novokhatny V. - IMPORTANCE OF FIBRIN BINDING FOR THERAPEUTIC EFFICACY OF DIRECT THROMBOLYTICS
Nowak T. - AN INTEGRATED APPROACH TO EFFECTIVE PATHOGEN REDUCTION FOR A PLASMA-DERIVED VWF/FVIII CONCENTRATE
  - EFFECTIVE PATHOGEN REDUCTION FOR A PLASMA-DERIVED PROTHROMBIN COMPLEX CONCENTRATE THROUGH MULTIPLE DEDICATED MEASURES
Nowak G. - PHARMACOKINETICS OF DIPETARUDIN AND PEG-DIPETARUDIN IN PIGS
  - FIRST EXPERIENCE WITH THROGA (THROMBIN GENERATION ASSAY) IN IDENTIFICATION OF HYPER- AND HYPOCOAGULABILITY
Nowak- Göttl U. - DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
Nowak-Gottl U. - THE FACTOR II G20210A VARIANT, POOR PATENCY RATES, AND OLDER AGE AT ONSET ARE INDEPENDENT RISK FACTORS FOR RECURRENT VENOUS THROMBOEMBOLISM
  - ROLE OF ELEVATED ALPHA2-MACROGLOBULIN REVISITED: RESULTS OF A CASE-CONTROL STUDY IN CHILDREN WITH SYMPTOMATIC THROMBOEMBOLISM
  - HAPLOTYPES OF THE PROTEIN Z GENE ASSOCIATED WITH SYMPTOMATIC THROMBOEMBOLISM IN CHILDREN
Nowak-Göttl U. - PROSPECTIVE POST LICENSURE SURVEILLANCE OF EFFICACY AND TOLERABILITY OF A HIGH PURITY, DOUBLE VIRUS INACTIVATED VWF/FVIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND'S DISEASE
Nowak-Gottl U. - EFFECTS OF THE FACTOR V G1691A MUTATION AND THE FACTOR II G20210A VARIANT ON THE CLINICAL EXPRESSION OF SEVERE HEMOPHILIA A ( 1%) IN CHILDREN
  - INFLUENCE OF HERITABILITY AND HOUSEHOLD COMPONENTS ON LIPID CONCENTRATIONS AND CLOTTING FACTOR LEVELS IN 282 PEDIATRIC STROKE FAMILIES
  - PAEDIATRIC STROKE
Nozaki M. - THE UTILITY OF QUANTITATIVE CALF MUSCLE NEARINFRARED SPECTROSCOPY IN THE FOLLOWUP OF ACUTE DEEP VEIN THROMBOSIS
Nozaki C. - HIGH-YIELD PRODUCTION AND CHARACTERIZATION OF RECOMBINANT APROTININ IN SACCHAROMYCES CEREVISIAE
Nozaki M. - PREVALENCE AND DISTRIBUTION OF DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM
  - DOES DIFFERENT D-DIMER LEVEL REDUCE THE USE OF VENOUS DUPLEX SCANNING TO RULE OUT DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM?
Nozzoli C. - DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS?
Nugent D.J. - THE EFFECT OF TEST CONDITIONS ON THROMBOELASTOGRAPHY PARAMETERS IN HEMOPHILIACS WITH AND WITHOUT INHIBITORS
  - A NOVEL MUTATION IN EXON 10 OF FACTOR XIII SUBUNIT B
Nugent D. - THE ROLE OF FC-GAMMA RECEPTOR GENE POLYMORPHISMS IN THE CLINICAL OUTCOME OF NEWLY DIAGNOSED ITP IN CHILDREN
Nugent D.J. - PROTEOMIC ANALYSIS IN PLATELET DYSFUNCTION
  - FACTOR XIII PHARMACOKINETICS
Numera V. - RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
Nunes S.S. - SYNDECAN-4 CONTRIBUTES TO ENDOTHELIAL TUBULOGENESIS THROUGH INTERACTIONS WITH TWO MOTIFS INSIDE THE PRO-ANGIOGENIC N-TERMINAL DOMAIN OF THROMBOSPONDIN-1
Nunez R. - MILD HAEMOPHILIA A (P. A1824T) ASSOCIATED WITH HEREDITARY COAGULATION FACTOR XII DEFICIENCY AND HETEROZYGOUS PROTHROMBIN 20210G/A MUTATION
  - HANDHELD COMPUTERS: AN EFFECTIVE SYSTEM TO RECORD HOME-THERAPY DATA OF PATIENTS WITH HAEMOPHILIA
  - PRIMARY KNEE ARTHOPLASTY USING RECOMBINANT FACTOR VIIA (RFVIIA) AS FIRST-LINE THERAPY IN HAEMOPHILIA PATIENTS WITH HIGH RESPONDING INHIBITORS
Nurden P. - A NEW LEU123 TO PRO MUTATION IN THE FIFTH LEUCINE-RICH REPEAT OF GLYCOPROTEIN IBALPHA IN A BERNARD-SOULIER PATIENT INDUCES DEFECTIVE SHEAR-DEPENDENT CELL ADHESION ON VON WILLEBRAND FACTOR
Nurden A.T. - ABCIXIMAB-DEPENDENT THROMBOCYTOPENIA IN PATIENTS WITH ACUTE CORONARY SYNDROMES CAN OCCUR BY DIFFERENT MECHANISMS
Nurden P. - ABCIXIMAB-DEPENDENT THROMBOCYTOPENIA IN PATIENTS WITH ACUTE CORONARY SYNDROMES CAN OCCUR BY DIFFERENT MECHANISMS
  - PAR4 INDUCES FULL PLATELET SPREADING ON A FIBRINOGEN MATRIX: INVOLVEMENT OF ERK2 AND P38 AND CA2+ MOBILIZATION
Nurden A.T. - TREATMENT OF GASTROINTESTINAL BLEEDING AND ANGIODYSPLASIA IN GLANZMANN THROMBASTHENIA WITH OCTREOTIDE
Nurden P. - TREATMENT OF GASTROINTESTINAL BLEEDING AND ANGIODYSPLASIA IN GLANZMANN THROMBASTHENIA WITH OCTREOTIDE
  - PLATELET ABNORMALITIES IN PATIENTS WITH CONSTITUTIONAL DEFECTS IN FILAMIN A
Nurden A.T. - PLATELET ABNORMALITIES IN PATIENTS WITH CONSTITUTIONAL DEFECTS IN FILAMIN A
  - HETEROGENEITY WITHIN THE PROTEIN CONTENT OF SECRETORY ORGANELLES OF HUMAN PLATELETS
Nurden P. - HETEROGENEITY WITHIN THE PROTEIN CONTENT OF SECRETORY ORGANELLES OF HUMAN PLATELETS
  - IDENTIFICATION AND EXPRESSION OF R763G MUTATION ABOLISHING THE CLEAVAGE OF VON WILLEBRAND FACTOR PROPEPTIDE, AT THE HETEROZYGOUS AND HOMOZYGOUS STATE
Nurden A. - IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
Nurden P. - IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA
Nurden A.T. - BERNARD-SOULIER PLATELETS EXPOSE MORE PROCOAGULANT PHOSPHATIDYLSERINE (PS), WITH PAR1 AND PAR4 MEDIATING THE SYNERGISTIC EFFECT OF THROMBIN ON COLLAGEN-STIMULATED PS EXPRESSION
Nurden P. - CALCIUM PUMPS AND ER STRESS MODULATIONS DURING THROMBOPOIESIS
Nutescu E.A. - EFFICACY AND SAFETY OF WARFARIN MANAGEMENT IN US ANTICOAGULATION CLINICS
Nuttall P. - VARIEGIN, A NOVEL CLASS OF THROMBIN INHIBITOR FROM THE SALIVARY GLAND EXTRACT OF THE HARD TICK AMBLYOMMA VARIEGATUM
Nyborg N.C.B. - EFFECT OF MICROSPHERE EMBOLI ON THE VENTILATION-PERFUSION RELATIONSHIP IN THE RABBIT - A PILOT STUDY
Nygaard F.B. - IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN
Nykjaer A. - INHIBITION OF PLATELET-DERIVED GROWTH FACTOR-BB (PDGF-BB) FUNCTION BY FACTOR VII ACTIVATING PROTEASE (FSAP): ROLE OF PROTEASE NEXIN-1 (PN-1) AND LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP)
Nylaende M. - BENEFICIAL EFFECT OF 1-YEAR OPTIMAL MEDICAL TREATMENT, INDEPENDENT OF ADDITIONAL PTA, ON INFLAMMATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD)
Nylander M. - THE PERIODONTAL PATHOGEN PORPHYROMONAS GINGIVALIS INDUCES BLOOD COAGULATION THROUGH ACTIVATION OF FACTOR XI BY GINGIPAIN R
Nylander S. - INHIBITION OF THROMBOSIS BY AZD6140 VIA SELECTIVE BLOCKADE OF THE P2Y12 RECEPTOR IN A MURINE LASER-INJURY MODEL
| ISTH 2009